One study in 63 MPN patients found a rise in PD-1 and PD-L1 expression at the surface of many cell types including CD4+, CD8+, CD14+, and CD34+ cells, regardless of the patient’s mutational status [124]. Here, CD34 is linked to myeloproliferative neoplasm.